Imperagen raises £5 million to use quantum physics and AI for enzyme engineering

Imperagen raised a £5 million seed round led by PXN Ventures, with backing from IQ Capital and Northern Gritstone.

The Manchester University spinout uses quantum physics simulations, custom AI, and robot-led experimentation to speed up enzyme engineering.

The company appointed Guy Levy-Yurista as CEO and plans to expand its team, lab, R&D, and commercial operations.

The funding could help cut enzyme development costs and improve industrial uses in pharma, food, and sustainable manufacturing.